-
-
-
-
-
-
-
LifeMD to Report First Quarter 2026 Financial Results on May 6
-
-
-
-
-
-
-
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
-
-
-
-
-
-
-
LifeMD adds Novo Nordisk's oral Wegovy pill to telehealth platform
-
-
-
-
-
-
-
LifeMD reduces cash prices for Wegovy and Ozempic to $199 monthly
-
-
-
-
-
-
-
LifeMD offers Ozempic at $499 monthly via Novo Nordisk partnership
-
-
-
-
-
-
-
Medifast Announces Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
LifeMD, Inc. (LFMD) Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

